拖累
发表于 2025-3-21 16:19:21
书目名称Cancer Immunology影响因子(影响力)<br> http://impactfactor.cn/if/?ISSN=BK0221129<br><br> <br><br>书目名称Cancer Immunology影响因子(影响力)学科排名<br> http://impactfactor.cn/ifr/?ISSN=BK0221129<br><br> <br><br>书目名称Cancer Immunology网络公开度<br> http://impactfactor.cn/at/?ISSN=BK0221129<br><br> <br><br>书目名称Cancer Immunology网络公开度学科排名<br> http://impactfactor.cn/atr/?ISSN=BK0221129<br><br> <br><br>书目名称Cancer Immunology被引频次<br> http://impactfactor.cn/tc/?ISSN=BK0221129<br><br> <br><br>书目名称Cancer Immunology被引频次学科排名<br> http://impactfactor.cn/tcr/?ISSN=BK0221129<br><br> <br><br>书目名称Cancer Immunology年度引用<br> http://impactfactor.cn/ii/?ISSN=BK0221129<br><br> <br><br>书目名称Cancer Immunology年度引用学科排名<br> http://impactfactor.cn/iir/?ISSN=BK0221129<br><br> <br><br>书目名称Cancer Immunology读者反馈<br> http://impactfactor.cn/5y/?ISSN=BK0221129<br><br> <br><br>书目名称Cancer Immunology读者反馈学科排名<br> http://impactfactor.cn/5yr/?ISSN=BK0221129<br><br> <br><br>
Daily-Value
发表于 2025-3-21 20:34:36
Strategies to Target Tumor Immunosuppression,osuppression, are pivotal for potent antitumor immunity..This chapter provides an overview of the main immune tolerance and immunosuppression mechanisms within the tumor microenvironment and discusses effective immunotherapeutic interventions that target homing and activity of immune effector cells
Etymology
发表于 2025-3-22 03:09:55
http://reply.papertrans.cn/23/2212/221129/221129_3.png
Respond
发表于 2025-3-22 07:29:43
http://reply.papertrans.cn/23/2212/221129/221129_4.png
Cabinet
发表于 2025-3-22 10:01:30
Combination of Chemotherapy and Cytokine Therapy in Treatment of Cancers,okines have demonstrated potential for therapeutic synergy. For example, it is possible to potentiate the development of specific immune response by reducing the dose of conventional chemotherapy (e.g., cyclophosphamide, gemcitabine, paclitaxel, and doxorubicin). This chapter provides currently evid
背带
发表于 2025-3-22 14:33:42
http://reply.papertrans.cn/23/2212/221129/221129_6.png
背带
发表于 2025-3-22 20:41:35
http://reply.papertrans.cn/23/2212/221129/221129_7.png
FLASK
发表于 2025-3-22 23:33:33
Adoptive T-Cell Therapy: Optimizing Chemokine Receptor-Mediated Homing of T-Cells in Cancer Immunotoited to improve T-cell homing to tumors. The possibility of developing novel strategies to bring more T-cell effectors into tumors will surely enhance the efficacy of adoptive T-cell therapies. These strategies, also in combination with current checkpoint blockade, hold great promise for the future
Embolic-Stroke
发表于 2025-3-23 01:36:34
Toll-Like Receptor Pathway and Its Targeting in Treatment of Cancers,ancer progression. Hence, more investigations are required to discover proper therapeutic approaches for cancer. Multiple trials have been designed recently to detect the therapeutic role of TLR agonist in addition to chemotherapy. Also, the role of TLR agonist as a vaccine adjuvant for different ty
Migratory
发表于 2025-3-23 08:59:14
http://reply.papertrans.cn/23/2212/221129/221129_10.png